FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Pops Diabetes Care Gets FDA Clearance for Blood Glucose Monitor

Dec. 10, 2018

Pops Diabetes’ Pops! one blood glucose monitoring system has received FDA clearance, and plans to begin commercialization in early 2019.

The device attaches directly to the back of a smartphone and is used by the patient through a coaching app.

The app enables users to review their blood glucose trends and share their data with healthcare professionals and family.

View today's stories